These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thirty years of HIV and AIDS: future challenges and opportunities. Dieffenbach CW; Fauci AS Ann Intern Med; 2011 Jun; 154(11):766-71. PubMed ID: 21628350 [TBL] [Abstract][Full Text] [Related]
4. HIV/AIDS in Asia. Ruxrungtham K; Brown T; Phanuphak P Lancet; 2004 Jul 3-9; 364(9428):69-82. PubMed ID: 15234860 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Schnittman SM; Fauci AS Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958 [TBL] [Abstract][Full Text] [Related]
6. Potential of polymeric nanoparticles in AIDS treatment and prevention. Khalil NM; Carraro E; Cótica LF; Mainardes RM Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001 [TBL] [Abstract][Full Text] [Related]
7. [Immunologic control of HIV-1 infection. Fantasy or soon reality?]. Heiken H; Stoll M; Valor L; Weber K; Horvath T; Schmidt RE MMW Fortschr Med; 2003 Apr; 145 Spec No 1():50-4. PubMed ID: 15011590 [TBL] [Abstract][Full Text] [Related]
8. Investing to meet the scientific challenges of HIV/AIDS. Fauci AS; Folkers GK Health Aff (Millwood); 2009; 28(6):1629-41. PubMed ID: 19887404 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696 [TBL] [Abstract][Full Text] [Related]
10. Progress towards an HIV-1 subtype C vaccine. Nkolola JP; Essex M Vaccine; 2006 Jan; 24(4):391-401. PubMed ID: 16139396 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus infection and AIDS in east Africa: challenges and possibilities for prevention and control. Mhalu FS; Lyamuya E East Afr Med J; 1996 Jan; 73(1):13-9. PubMed ID: 8625855 [TBL] [Abstract][Full Text] [Related]
12. Live and let live. Rao KS J Indian Med Assoc; 2002 Dec; 100(12):712, 714, 716. PubMed ID: 12793638 [TBL] [Abstract][Full Text] [Related]
13. HIV: epidemiology and strategies for therapy and vaccination. Marcus U; Dittmar MT; Kräusslich HG Intervirology; 2002; 45(4-6):260-6. PubMed ID: 12566708 [TBL] [Abstract][Full Text] [Related]
14. [News in HIV/AIDS therapy]. Calmy A; Cavassini M Rev Med Suisse; 2012 Jan; 8(324):130-4. PubMed ID: 23185824 [TBL] [Abstract][Full Text] [Related]
15. HIV: medical milestones and clinical challenges. Halligan KP; Halligan TJ; Jeske AH; Koh SH Dent Clin North Am; 2009 Apr; 53(2):311-22, x. PubMed ID: 19269399 [TBL] [Abstract][Full Text] [Related]
16. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of human immunodeficiency virus in the United States. Hariri S; McKenna MT Clin Microbiol Rev; 2007 Jul; 20(3):478-88, table of contents. PubMed ID: 17630336 [TBL] [Abstract][Full Text] [Related]
18. [Program DREAM (Drug Resource Enhancement against AIDS in Mozambique]. Assist Inferm Ric; 2003; 22(2):121-6. PubMed ID: 13677167 [No Abstract] [Full Text] [Related]
19. HIV/AIDS treatment and HIV vaccines for Africa. Weidle PJ; Mastro TD; Grant AD; Nkengasong J; Macharia D Lancet; 2002 Jun; 359(9325):2261-7. PubMed ID: 12103304 [TBL] [Abstract][Full Text] [Related]
20. [The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era]. Madeddu G; Calia GM; Lovigu C; Mannazzu M; Maida I; Babudieri S; Rezza G; Mura MS Ann Ist Super Sanita; 2006; 42(2):197-202. PubMed ID: 17033141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]